unknown
Stage
1
Investors
About
Annexon Biosciences develops therapeutics targeting the complement system to treat autoimmune and neurodegenerative diseases.
Explore Annexon Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.